Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population

Journal of Lipid Research

Volumn 40, Issue 3, 1999, Pages 432-438

  Bersot, Thomas P ^a,b   Vega, Gloria Lena ^c   Grundy, Scott M ^c   Palaoǧlu, K Erhan ^d   Atagündüz, Pamir ^d   Özbayrakçi, Sinan ^d   Gökdemir, Oryal ^d   Mahley, Robert W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d AMERICAN HOSPITAL   (Turkey)

Author keywords

Apolipoprotein A I; Body mass index; Cholesteryl ester transfer protein; Lecithin:cholesterol acyltransferase; Lipoprotein lipase; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ETHNIC DIFFERENCE; FEMALE; GENETIC ASSOCIATION; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; TURKEY (REPUBLIC);

ADULT; AGE FACTORS; BODY MASS INDEX; CHOLESTEROL, HDL; FEMALE; HUMANS; LIPASE; LIPOPROTEIN(A); LIVER; MALE; MIDDLE AGED; SAN FRANCISCO; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES; TURKEY;

EID: 0032969864     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. National Cholesterol Education Program. 1994. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 89: 1329-1445.
2. Miller, N. E., O. H. Førde, D. S. Thelle, and O. D. Mjøs. 1977. The Tromsø Heart-Study. High-density lipoprotcin and coronary heart-disease: a prospective case-control study. Lancet. 1: 965-968.
3. Gordon, T., W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 62: 707-714.
4. Assmann, G., and H. Funke. 1990. HDL metabolism and atherosclerosis. J. Cardiovasc. Pharmacol. 16 (Suppl. 9): S15-S20.
5. Genest, J. J., Jr., S. S. Martin-Munley, J. R. McNamara, J. M. Ordovas, J. Jenner, R. H. Myers, S. R. Silberman, P. W. F. Wilson, D. N. Salem, and E. J. Schaefer. 1992. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation. 85: 2025-2033.
6. Schaefer, E. J., S. Lamon-Fava, J. M. Ordovas, S. D. Cohn, M. M. Schaefer, W. P. Castelli, and P. W. F. Wilson. 1994. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J. Lipid Res. 35: 871-882.
7. Grundy, S. M., and M. A. Denke. 1990. Dietary influences on serum lipids and lipoproteins. J. Lipid Res. 31: 1149-1172.
8. Kris-Etherton, P. M., J. Derr, D. C. Mitchell, V. A. Mustad, M. E. Russell, E. T. McDonnell, D. Salabsky, and T. A. Pearson. 1993. The role of fatty acid saturation on plasma lipids, lipoproteins, and apolipoproteins: I. Effects of whole food diets high in cocoa butter, olive oil, soybean oil, dairy butter, and milk chocolate on the plasma lipids of young men. Metabolism. 42: 121-129.
9. Mattson, F. H., and S. M. Grundy. 1985. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J. Lipid Res. 26: 194-202.
10. Craig, W. Y., G. E. Palomaki, and J. E., Haddow. 1989. Cigarette smoking and serum lipid and lipoprotein concentrations: An analysis of published data. Br. Med. J. 298: 784-788.
11. Denke, M. A., C. T. Sempos, and S. M. Grundy. 1993. Excess body weight. An underrecognized contributor to high blood cholesterol levels in while American men. Arch. Intern. Med. 153: 1093-1103.
12. Denke, M. A., C. T. Sempos, and S. M. Grundy. 1994. Excess body weight. An under-recognized contributor to dyslipidemia in white American women. Arch. Intern. Med. 154: 401-410.
13. Mensink, R. P., and M. B. Katan. 1992. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler. Thromb. 12: 911-919.
14. Schaefer, E. J. 1984. Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency. Arteriosclerosis. 4: 303-322.
15. Vega, G. L., and S. M. Grundy. 1996. Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease. Curr. Opin. Lipidol. 7: 209-216.
16. Cohen, J. C., Z. Wang, S. M. Grundy, M. R. Stoesz, and R. Guerra. 1994. Variation at the hepatic lipase and apolipoprotein AI/CIII/ AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J. Clin. Invest. 94: 2377-2384.
17. Mahley, R. W., K. E. Palaoglu, Z. Atak, J. Dawson-Pepin, A-M. Langlois, V. Cheung, H. Onat, P. Fulks, L. L. Mahley, F. Vakar, S. Özbayrakçi, O. Gökdemir, and W. Winkler. 1995. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J. Lipid Res. 36: 839-859.
18. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
19. 2. Clin. Chem. 29: 2026-2030.
20. Vega, G. L., and S. M. Grundy. 1989. Comparison of lovastatin and gemfibrozil in normolipidemic patients with hypoalphalipoproteinemia. J. Am. Med. Assoc. 262: 3148-3153.
21. Parra, H. J., H. Mezdour, N. Ghalim, J. M. Bard, and J. C. Fruchart. 1990. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Clin. Chem. 36: 1431-1435.
22. Tatò, F., G. L. Vega, and S. M. Grundy. 1997. Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Role of cholesteryl-ester transfer protein and lecithin:cholesteryl acyl transferase. Arterioscler. Thromb. Vasc. Biol. 17:56-63.
23. Tatò, F., G. L. Vega, A. R. Tall, and S. M. Grundy. 1995. Relation between cholesteryl ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 15: 112-120.
24. Blades, B., G. L. Vega, and S. M. Grundy. 1993. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler. Thromb. 13: 1227-1235.
25. Bensadoun, A. 1996. Sandwich immunoassay for measurement of human hepatic lipase. Methods Enzymol. 263: 333-338.
26. The Lipid Research Clinics. 1980. Population Studies Data Book. The Prevalence Study. Bethesda, MD.
27. Lüttmann, S., A. von Eckardstein, W. Wei, H. Funke, E. Köhler, R. W. Mahley, and G. Assmann. 1994. Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45→Asn), in a Turkish patient. J. Lipid Res. 35: 1431-1440.
28. Rader, D. J., and K. Ikewaki. 1996. Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models. Curr. Opin. Lipidol. 7: 117-123.
29. Rosenson, R. S. 1996. Beyond low-density lipoprotein cholesterol. A perspective on low high-density lipoprotein disorders and Lp(a) lipoprotein excess. Arch. Intern. Med. 156: 1278-1284.
30. Galton, D. J. 1995. Common genetic determinants of dyslipidemia: The hypertriglyceridemia/low-high-density lipoprotein syndrome. J. Cardiovasc. Pharmacol. 25 (Suppl. 4): S35-S40.
31. Bard, J. M., and J. G. Fruchart. 1993. Triglyceride-rich particles, high-density lipoprotein and their pharmacological modulation. Biochem. Soc. Trans. 21: 647-649.
32. Silverman, D. I., G. S. Ginsburg, and R. C. Pasternak. 1993. High-density lipoprotein subfractions. Am. J. Med. 94: 636-645.
33. Taylor, P. A., and A. Ward. 1993. Women, high-density lipoprotein cholesterol, and exercise. Arch. Intern. Med. 153: 1178-1184.
34. Patsch, W., and A. M. Gotto, Jr. 1995. High-density lipoprotein cholesterol, plasma triglyceride, and coronary heart disease: Pathophysiology and management. Adv. Pharmacol. 32: 375-426.
35. Nie, L., J. Wang, L. T. Clark, A. Tang, G. L. Vega, S. M. Grundy, and J. C. Cohen. 1998. Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J. Lipid Res. 39: 1127-1130.
36. Boberg, J., M. Boberg, R. Gross, J. D. Turner, J. Augustin, and W. V. Brown. 1979. Hepatic triglyceride and lipoprotein lipase activities of post-heparin plasma in normals and hypertriglyceridemics. Upsala J. Med. Sci. 84: 215-227.
37. 2-cholesterol and increase hepatic triglyceride lipase activity. Med. Sci. Sports Exercise. 17: 462-465.
38. 2 cholesterol. Metabolism. 36: 949-952.
39. Cominacini, L., U. Garbin, A. Davoli, M. Campagnola, A. De Santis, C. Pasini, A. M. Pastorino, and O. Bosello. 1993. High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: Relationships with plasma insulin levels. Ann. Nutr. Metab. 37: 175-184.
40. Després, J-P., M. Ferland, S. Moorjani, A. Nadeau, A. Tremblay, P. J. Lupien, G. Thériault, and C. Bouchard. 1989. Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis. 9: 485-492.
41. Vega, G. L., L. T. Clark, A. Tang, S. Marcovina, S. M. Grundy, and J. C. Cohen. 1998. Hepatic lipase activity is lower in African American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J. Lipid Res. 39: 228-232.
42. Laws, A., J. L. Jeppesen, P. C. Maheux, P. Schaaf, Y-D. Ida Chen, and G. M. Reaven. 1994. Resistance to insulin-stimulated glucose uptake and dyslipidemia in Asian Indians. Arterioscler. Thromb. 14: 917-922.
43. McKeigue, P. M., B. Shah, and M. G. Marmot. 1991. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 337: 382-386.
44. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1991. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J. Clin. Invest. 87: 536-544.